Bicycle Therapeutics PLC (NASDAQ:BCYC)
| 53.67 Delayed Data As of 4:00pm ET |  -0.33 / -0.61%Today’s Change | 17.95 Today|||52-Week Range 62.08 | +199.00% Year-to-Date |
Latest BCYC News | Press Releases
No recent news for Bicycle Therapeutics PLC.
Today’s Trading
| Previous close | 54.00 |
| Today’s open | 54.15 |
| Day’s range | 53.65 - 55.06 |
| Volume | 6,899 |
| Average volume (3 months) | 280,501 |
| Market cap | $1.6B |
Data as of 4:00pm ET, 11/30/2021
Growth & Valuation
| Earnings growth (last year) | +3.51% |
| Earnings growth (this year) | -1.88% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -24.44% |
| P/E ratio | NM |
| Price/Sales | 32.82 |
| Price/Book | 11.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ATRAAtara Biotherapeutic... | +0.09 | +0.51% |
| ALECAlector Inc | +1.20 | +6.19% |
| PTGXProtagonist Therapeu... | +1.14 | +3.50% |
| RCKTRocket Pharmaceutica... | +0.74 | +3.13% |
Data as of 4:00pm ET, 11/30/2021
Financials
| Next reporting date | March 15, 2022 |
| EPS forecast (this quarter) | -$0.63 |
| Annual revenue (last year) | $10.5M |
| Annual profit (last year) | -$51.4M |
| Net profit margin | -490.95% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
